Lactobacillus acidophilus Improves Intestinal Inflammation in an Acute Colitis Mouse Model by Regulation of Th17 and Treg Cell Balance and Fibrosis Development

Journal of Medicinal Food

Volumn 21, Issue 3, 2018, Pages 215-224

  Park, Jin Sil ^a   Choi, Jeong Won ^a   Jhun, JooYeon ^a   Kwon, Ji Ye ^a   Lee, Bo In ^b   Yang, Chul Woo ^b   Park, Sung Hwan ^a,b   Cho, Mi La ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

fibrosis; inflammatory bowel disease; L. acidophilus; Th17 cell; Treg cell

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; DEXTRAN SULFATE; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR; ACTIN; ALPHA-SMOOTH MUSCLE ACTIN, MOUSE; BIOLOGICAL MARKER; CYTOKINE; IL10 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; COLON TISSUE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEXTRAN SULFATE SODIUM-INDUCED COLITIS; ENTERITIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; INTESTINAL FIBROSIS; LACTOBACILLUS ACIDOPHILUS; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL; TH17 CELL; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; COLITIS; COLON; DIET THERAPY; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; GERMFREE ANIMAL; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; RANDOMIZATION; SECRETION (PROCESS); SPLEEN;

ACTINS; ANIMALS; BIOMARKERS; CELLS, CULTURED; COLITIS; COLLAGEN TYPE I; COLON; CYTOKINES; FIBROSIS; GENE EXPRESSION REGULATION; INTERLEUKIN-10; INTESTINAL MUCOSA; LACTOBACILLUS ACIDOPHILUS; MALE; MICE, INBRED C57BL; MYOFIBROBLASTS; PROBIOTICS; RANDOM ALLOCATION; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 85044682465     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2017.3990     Document Type: Article

References (34)

1. Podolsky DK: Inflammatory bowel disease. N Engl J Med 2002; 347:417-429.
2. Xavier RJ, Podolsky DK: Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007;448:427-434.
3. Abraham C, Cho JH: Inflammatory bowel disease. N Engl J Med 2009;361:2066-2078.
4. Van Assche G, Geboes K, Rutgeerts P: Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis 2004;10:55-60.
5. Speca S, Giusti I, Rieder F, Latella G: Cellular and molecular mechanisms of intestinal fibrosis. World J Gastroenterol 2012; 18:3635-3661.
6. Fiocchi C, Lund PK: Themes in fibrosis and gastrointestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2011;300: G677-G683.
7. Galvez J: Role of Th17 Cells in the pathogenesis of human IBD. ISRN Inflamm 2014;2014:928461.
8. Bouma G, Strober W: The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003;3:521-533.
9. Liu ZJ, Yadav PK, Su JL, Wang JS, Fei K: Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2009;15:5784-5788.
10. Owaga E, Hsieh RH, Mugendi B, Masuku S, Shih CK, Chang JS: Th17 cells as potential probiotic therapeutic targets in inflammatory bowel diseases. Int J Mol Sci 2015;16:20841-20858.
11. Holtta V, Klemetti P, Salo HM, et al.: Interleukin-17 immunity in pediatric Crohn's disease and ulcerative colitis. J Pediatr Gastroenterol Nutr 2013;57:287-292.
12. Ueno A, Jijon H, Chan R, et al.: Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Inflamm Bowel Dis 2013; 19:2522-2534.
13. Sahin A, Calhan T, Cengiz M, et al.: Serum interleukin 17 levels in patients with Crohn's disease: Real life data. Dis Markers 2014;2014:690853.
14. Ito R, Kita M, Shin-Ya M, et al.: Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Biochem Biophys Res Commun 2008;377:12-16.
15. Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK: Critical role of IL-17 receptor signaling in acute TNBS-induced colitis. Inflamm Bowel Dis 2006;12:382-388.
16. Maul J, Loddenkemper C, Mundt P, et al.: Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 2005;128:1868-1878.
17. Gomes-Santos AC, Moreira TG, Castro-Junior AB, et al.: New insights into the immunological changes in IL-10-deficient mice during the course of spontaneous inflammation in the gut mucosa. Clin Dev Immunol 2012;2012:560817.
18. Shibolet O, Karmeli F, Eliakim R, et al.: Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis 2002;8:399-406.
19. Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 2003;361:512-519.
20. Chen L, Zou Y, Peng J, et al.: Lactobacillus acidophilus suppresses colitis-associated activation of the IL-23/Th17 axis. J Immunol Res 2015;2015:909514.
21. Suzuki K, Sun X, Nagata M, et al.: Analysis of intestinal fibrosis in chronic colitis in mice induced by dextran sulfate sodium. Pathol Int 2011;61:228-238.
22. Hamamoto N, Maemura K, Hirata I, Murano M, Sasaki S, Katsu K: Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1)). Clin Exp Immunol 1999;117:462-468.
23. Zhang L, Zhao Y: The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: Multiple pathways on the road. J Cell Physiol 2007;211:590-597.
24. Sullivan A, Nord CE: Probiotics and gastrointestinal diseases. J Intern Med 2005;257:78-92.
25. Erickson KL, Hubbard NE: Probiotic immunomodulation in health and disease. J Nutr 2000;130:403S-409S.
26. Macfarlane GT, Cummings JH: Probiotics, infection and immunity. Curr Opin Infect Dis 2002;15:501-506.
27. Parvez S, Malik KA, Ah Kang S, Kim HY: Probiotics and their fermented food products are beneficial for health. J Appl Microbiol 2006;100:1171-1185.
28. Stanton C, Gardiner G, Meehan H, et al.: Market potential for probiotics. Am J Clin Nutr 2001;73:476S-483S.
29. Li AL, Meng XC, Duan CC, Huo GC, Zheng QL, Li D: Suppressive effects of oral administration of heat-killed Lactobacillus acidophilus on T helper-17 immune responses in a bovine beta-lactoglobulin-sensitized mice model. Biol Pharm Bull 2013; 36:202-207.
30. Roselli M, Finamore A, Nuccitelli S, et al.: Prevention of TNBSinduced colitis by different Lactobacillus and Bifidobacterium strains is associated with an expansion of gammadeltaT and regulatory T cells of intestinal intraepithelial lymphocytes. Inflamm Bowel Dis 2009;15:1526-1536.
31. Fichera A, Lovadina S, Rubin M, Cimino F, Hurst RD, Michelassi F: Patterns and operative treatment of recurrent Crohn's disease: A prospective longitudinal study. Surgery 2006;140: 649-654.
32. Liu Y, Zhu H, Su Z, et al.: IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCbeta/ Erk1/2/NF-kappaB-dependent signaling pathway. Int Immunol 2012;24:605-612.
33. Okamoto Y, Hasegawa M, Matsushita T, et al.: Potential roles of interleukin-17A in the development of skin fibrosis in mice. Arthritis Rheum 2012;64:3726-3735.
34. Valente AJ, Yoshida T, Gardner JD, Somanna N, Delafontaine P, Chandrasekar B: Interleukin-17A stimulates cardiac fibroblast proliferation and migration via negative regulation of the dual-specificity phosphatase MKP-1/DUSP-1. Cell Signal 2012; 24:560-568.